JP2025111445A5 - - Google Patents
Info
- Publication number
- JP2025111445A5 JP2025111445A5 JP2025050172A JP2025050172A JP2025111445A5 JP 2025111445 A5 JP2025111445 A5 JP 2025111445A5 JP 2025050172 A JP2025050172 A JP 2025050172A JP 2025050172 A JP2025050172 A JP 2025050172A JP 2025111445 A5 JP2025111445 A5 JP 2025111445A5
- Authority
- JP
- Japan
- Prior art keywords
- oligomer
- formula
- branched
- linear
- alkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP19161716.6 | 2019-03-08 | ||
| EP19161716 | 2019-03-08 | ||
| JP2021552816A JP7728704B2 (ja) | 2019-03-08 | 2020-03-06 | 炭素環誘導体及びそれらのコンジュゲート誘導体、並びにワクチンにおけるそれらの使用 |
| PCT/EP2020/055950 WO2020182635A1 (en) | 2019-03-08 | 2020-03-06 | Carbocyclic derivatives and conjugated derivatives thereof, and their use in vaccines |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021552816A Division JP7728704B2 (ja) | 2019-03-08 | 2020-03-06 | 炭素環誘導体及びそれらのコンジュゲート誘導体、並びにワクチンにおけるそれらの使用 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025111445A JP2025111445A (ja) | 2025-07-30 |
| JP2025111445A5 true JP2025111445A5 (enExample) | 2025-10-31 |
Family
ID=66000932
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021552816A Active JP7728704B2 (ja) | 2019-03-08 | 2020-03-06 | 炭素環誘導体及びそれらのコンジュゲート誘導体、並びにワクチンにおけるそれらの使用 |
| JP2025050172A Pending JP2025111445A (ja) | 2019-03-08 | 2025-03-25 | 炭素環誘導体及びそれらのコンジュゲート誘導体、並びにワクチンにおけるそれらの使用 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021552816A Active JP7728704B2 (ja) | 2019-03-08 | 2020-03-06 | 炭素環誘導体及びそれらのコンジュゲート誘導体、並びにワクチンにおけるそれらの使用 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20220152183A1 (enExample) |
| EP (1) | EP3934696A1 (enExample) |
| JP (2) | JP7728704B2 (enExample) |
| CN (1) | CN114126662A (enExample) |
| BR (1) | BR112021017239A2 (enExample) |
| CA (1) | CA3131741A1 (enExample) |
| MX (1) | MX2021010555A (enExample) |
| WO (1) | WO2020182635A1 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB202115151D0 (en) | 2021-10-21 | 2021-12-08 | Glaxosmithkline Biologicals Sa | Methods |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0115176D0 (en) * | 2001-06-20 | 2001-08-15 | Chiron Spa | Capular polysaccharide solubilisation and combination vaccines |
| GB0220198D0 (en) * | 2002-08-30 | 2002-10-09 | Chiron Spa | Modified saccharides,conjugates thereof and their manufacture |
| JP4827726B2 (ja) | 2003-01-30 | 2011-11-30 | ノバルティス ヴァクシンズ アンド ダイアグノスティクス エスアールエル | 複数の髄膜炎菌血清群に対する注射可能ワクチン |
| GB0409750D0 (en) * | 2004-04-30 | 2004-06-09 | Chiron Srl | Integration of meningococcal conjugate vaccination |
| SI3110442T1 (sl) | 2014-02-28 | 2021-01-29 | Glaxosmithkline Biologicals S.A. | Modificirani meningokokni fHbp polipeptidi |
| GB202013262D0 (en) * | 2020-08-25 | 2020-10-07 | Glaxosmithkline Biologicals Sa | Vaccine Composition |
-
2020
- 2020-03-06 EP EP20708099.5A patent/EP3934696A1/en active Pending
- 2020-03-06 MX MX2021010555A patent/MX2021010555A/es unknown
- 2020-03-06 BR BR112021017239A patent/BR112021017239A2/pt unknown
- 2020-03-06 CN CN202080031171.4A patent/CN114126662A/zh active Pending
- 2020-03-06 WO PCT/EP2020/055950 patent/WO2020182635A1/en not_active Ceased
- 2020-03-06 CA CA3131741A patent/CA3131741A1/en active Pending
- 2020-03-06 JP JP2021552816A patent/JP7728704B2/ja active Active
- 2020-03-06 US US17/436,692 patent/US20220152183A1/en active Pending
-
2025
- 2025-03-25 JP JP2025050172A patent/JP2025111445A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2025111445A5 (enExample) | ||
| JP2013523897A5 (enExample) | ||
| US7862823B1 (en) | Multivalent vaccine composition with mixed carrier | |
| AU2010279299B2 (en) | Lipidated oxoadenine derivatives | |
| JP2014527974A5 (enExample) | ||
| JP2021503029A5 (enExample) | ||
| JP2018518201A5 (enExample) | ||
| RU2412944C2 (ru) | Иммуногены для вакцин против менингита а | |
| JP2013079285A5 (enExample) | ||
| RU2009130447A (ru) | Модифицированные сахариды | |
| JP2012017342A5 (enExample) | ||
| JP2008508315A5 (enExample) | ||
| RU2007127993A (ru) | Сахарид-конъюгатные вакцины | |
| JP2010515718A5 (enExample) | ||
| WO2007135910A1 (ja) | ポドフィロトキシン類の高分子結合体 | |
| JP2004502752A5 (enExample) | ||
| JP2011528654A5 (enExample) | ||
| JP2011500814A5 (enExample) | ||
| JPWO2008010463A1 (ja) | コンブレタスタチン類の高分子結合体 | |
| JP2020515688A5 (enExample) | ||
| JP2007534743A5 (enExample) | ||
| AU2017234319A1 (en) | Novel polysaccharide-protein conjugates and process to obtain thereof | |
| JP2002520288A5 (enExample) | ||
| JP2004534887A5 (enExample) | ||
| JP2012516347A5 (enExample) |